Skip to main content

Predictive role of depressive symptoms on frailty and its components in Chinese middle-aged and older adults: a longitudinal analysis

Abstract

Background

To investigate the cross-sectional and longitudinal associations between depressive symptoms and the prevalence of frailty and its components in a nationally representative sample of middle-aged and older Chinese adults.

Method

The China Health and Retirement Longitudinal Study (CHARLS) provided data on 2581 (after inclusion and exclusion criteria) adults aged ≥ 45 years. Every two years, face-to-face, computer-aided personal interviews (CAPI), and structured questionnaires were used to follow up with the respondents. The Chinese version of the Center for Epidemiologic Studies-Depression Scale (CES-D) was used to evaluate depressive symptoms, and the Fried criteria were used to measure frailty. The odds ratio (OR) and 95% confidence interval (CI) for the association of exposure (depressive symptoms at baseline) with the onset of the outcome (frailty and its components) in the individuals at baseline were analyzed by binary logistic regression.

Results

At baseline, 11.62% of participants had frailty, and 57.92% had depressive symptoms. In the cross-sectional analysis, depressive symptoms (OR = 5.222, 95%CI 3.665–7.442) were associated with frailty. In the longitudinal analysis, after adjusting for the full set of covariates among participants free of baseline frailty, depressive symptoms were significantly associated with incident frailty during the short term (OR = 2.193, 95%CI 1.324–3.631) and the long term (OR = 1.926, 95%CI 1.021–3.632). Meanwhile, depressive symptoms were associated with an increased risk of weakness (OR = 1.990, 95%CI 1.250–3.166), slowness (OR = 1.395, 95%CI 1.044–1.865), and exhaustion (OR = 2.827, 95%CI 2.150–3.719) onset during the short-term. Depressive symptoms were associated with an increased risk of exhaustion (OR = 2.869, 95%CI 2.004–4.109) onset during the long-term.

Conclusion

Among middle-aged and older adults, depressive symptoms could predict frailty during 2 years of follow-up and 4 years of follow-up. When considering potential confounding factors, depressive symptoms were considered a predictor of weakness, slowness, and exhaustion. Interventions aimed at preventing depressive symptoms may be beneficial in reducing frailty and its components.

Peer Review reports

Background

Frailty is defined by a loss of biological reserves, a failure of homeostasis mechanisms, and vulnerability to physical decompensation after minor influences or stresses [1]. A common biological syndrome model of frailty consists of exhaustion, weakness, low physical activity, slowness, and weight loss. Pre-frailty occurs when one or two of these factors are present, while frailty occurs when three or more are present [2]. As people age, they become more fragile, which increases their risk of several negative health consequences, including hospitalization, falls, and even death [3]. Depression is a common chronic medical illness that can impact one’s mood, thoughts, and physical health [4]. It is characterized by a lack of energy, a low mood, insomnia, sadness, and an inability to enjoy life [4]. In most clinical contexts, depression is assessed as a single condition or severity continuum. This combines varied symptomatology and reduces clinically meaningful information that is critical to diagnosis and treatment [5]. Depression in the older adults contributes to both dementia and a decline in functional ability [6]. Serious consequences like happiness, disability, and an increase in the load on families and society are linked to depressive symptoms [7]. Lifetime prevalence estimates (populational mean 13%) differ significantly between nations [8]. Depression has a prevalence of 10–20% in older adults [9], while it is more common when it comes to women [8], people with lower socioeconomic status [10], and people with less education [11]. Fiske et al. reported that depression is one of the most common mental diseases resulting in disability in late life [6]. According to a meta-analysis, the prevalence of depressive symptomatology is 17.1% in people 75 years of age and older and 19.5% in those 50 years of age and older [12]. The prevalence of geriatric depression disorders ranges from 12.7 to 33.8% in Asian nations [13]. Major depression is present in older adults at a rate of 4.6–9.3%, while subthreshold depression is two to three times more common than major depression [9]. In Taiwan, the major and minor depression prevalence rates for persons 55 years of age or older are approximately 1.5% and 3.7%, respectively [14].

Mounting evidence demonstrates that depression could be associated with frailty. In a cross-sectional study by Jung et al. involving 382 participants, depressive people were more likely to be frail when compared to those who did not have depression (OR = 5.25, 95% CI, 2.55–10.83) [15]. Older adults with depression have a higher prevalence of physical fragility than those without depression [16]. According to a 1.5-year cohort study involving 1602 Germans, the prevalence of frailty rose along with the growing prevalence of depression [17]. A recent meta-analysis, which combines four cohorts and ten cross-sectional observational studies, involving 84,351 community older adults, confirmed that older adults can become frail by depression and that older men with depression are more likely to become frail than their female counterparts [18]. In the Geriatric Clinic of “Dr. C. I. Parhon” Hospital, a retrospective study involving 411 patients found that frailty is positively correlated with depression [19]. Prospective studies of the connection between depression and incident frailty also showed that depression may raise the risk of frailty [20]. In longitudinal research, frailty and pre-frailty were linked to a 2.31-fold and 1.58-fold higher risk of incidence of depressive symptoms, respectively, compared with no frail individuals, after controlling for sociodemographic variables (e.g., age, gender, alcohol intake, smoking, etc.) [21]. Soysal et al.’s observations indicate that frailty and depression are both risk factors for the occurrence of each other [22]. Fugate Woods et al. indicated that the risk factors of frailty may result in functional dependence, or disability, and thus lead to depression [23]. Another review, including cross-sectional (n = 16) and longitudinal studies (n = 23) deemed that frailty and its components are risk factors for depression symptoms [24]. A cross-sectional examination of one prospective cohort of researchers revealed a correlation between depression and social frailty [25]. Additionally, according to two longitudinal investigations including 4852 older persons, frailty at baseline raised the risk of incident depression by about 90% [26, 27].

The meta-analysis emphasized the possible negative impact of depression on frailty and included both cohort and cross-sectional studies. The influence of depression on frailty and its components over a period of years in various research studies was not taken into account. Furthermore, in the meta-analysis, most participants were Western. Therefore, more research on middle-aged and older people in Asian countries is required to find the connection between depressive symptoms and the influence of frailty in Asian participants. In order to close these gaps, this research utilized 4-year longitudinal data from a nationally representative sample of Chinese participants who were 45 years of age or older. The research investigated the association between depressive symptoms and the incidence of frailty and its components during the 2 and 4-year internal studies. Additionally, by adjusting for relevant confounders, this research investigates the stability of the relationship between depressive symptoms, frailty, and its components.

Materials and methods

Study participants

The China Health and Retirement Longitudinal Study (CHARLS), which is a nationally representative longitudinal study, provided us with the data [28]. In 2011, the national baseline survey for CHARLS was conducted. It used four-stage probability sampling and the probability-proportional-to-size sampling technique [29]. First, all the counties in China were stratified according to the region, rural or urban, and gross domestic product per capita. To represent the socioeconomic and geographic distribution of all the counties, 150 randomly chosen counties were selected in the sample. Second, in each county, three primary sampling units were selected with a probability based on population size. Third, every household within the selected primary sampling unit was mapped, and 24 randomly chosen houses with residents aged 45 and above were selected from each primary sampling unit. Finally, one resident aged 45 and above from each selected household was randomly chosen as a participant in the survey. In 2011, 17,104 people aged 45 and older were included in the CHARLS cohort (Wave 1). Data collection then took place in 2013 (Waves 2) and 2015 (Waves 3). Every two years, face-to-face, computer-aided personal interviews (CAPI), and structured questionnaires will be used to follow up with the respondents. Data from individuals who took part in Waves 1, 2, and 3 were used in this study. At baseline, the inclusion criteria for this study were: (1) aged ≥ 45 years; (2) attended the baseline surveys. The exclusion criteria of the research were: (1) the presence of three or more components of frailty that include exhaustion, weakness, low activity, weight loss, and slowness; (2) no depressive symptoms data; (3) no age, sex, education, marital status, current residence, current smoking, alcohol drinking, taking activities, chronic diseases, or BMI categories data; and (4) no follow-up information. At the time of Wave 2 and Wave 3, the attrition rates were 58.62% and 43.16% respectively. The major reasons for the attrition were refusal to respond, health, inability to contact sample residents, and interviewer-related reasons [28]. There were 2581 people who finished both baselines, and the number of follow-up surveys was 1068 for the short term (two years, 2011–2013) and 607 for the long term (four years, 2011–2015) (Fig. 1).

Fig. 1
figure 1

Study procedure. CAPI: computer-aided personal interviews

Depressive symptom

The Center for Epidemiologic Studies-Depression Scale (CES-D) was applied in the research to measure depression symptoms in the last week [30, 31]. The scale has good content validity and structure validity, which is the Chinese version. The scale contains 10 items, which are divided into 3 dimensions, including depressed affect for 3 items, somatic symptoms for 5 items, and positive affect for 2 items. Each item used a four-point Likert scale coded from 0 (seldom or none of the time) to 3 (all of the time). 5 and 8 items are negatively stated; other items are positively stated. The total points score on the scale ranges from 0 to 30, and a higher score indicates greater degrees of depressive symptoms. As recommended by Andresen, the depressed symptom-total score ≥10 was established using harmonized criterion cutoff values. According to previous studies, the same cut-off point of depressive symptom-total score was validated among elderly respondents in China [32,33,34]. The CESD-10 has indicated good validity and reliability for the community-dwelling older adults in China [32, 35, 36]. The Cronbach’s alpha value for this section was 0.861.

Frailty assessment

Nowadays, the Fried model is the most commonly used and accepted as the standard for frailty evaluation [2]. The information from the CHARLS was used to modify it. In this conceptual model, frailty is reflected across five components: weakness, slowness, weight loss, exhaustion, and low activity. In this research, the following definitions and assessments were made of the five frailty components. Frailty refers to meeting three or more out of five components.

  1. (1)

    Weakness: According to Fried et al., the body mass index (BMI) and sex cutoff were used to define weakness as maximum grip strength [2]. Using a dynamometer, the maximal handgrip strength was measured three times on each side; the best measurement was selected in our analysis. For medical reasons, people who were unable to do the handgrip strength test were deemed weakness.

  2. (2)

    Slowness: Slowness means being below the 20th sex-specific percentile. A Timed Up and Go (TUG) test was used to measure gait speed [37]. The TUG test required research participants to get out of an armchair, walk three meters, and then get back in and sit down. The test started when the individual’s back left the armchair, and it ended when their buttocks made contact with the chair’s seat once more [38,39,40].

  3. (3)

    Weight loss: weight loss refers to the weight that has decreased by 5 kg or current body mass index (BMI) ≤ 18.5 kg/m2 during the last 12 months [41, 42].

  4. (4)

    Exhaustion: Exhaustion refers to the response to two items from the CES-D: (1) “I thought that everything I did was an effort”; and (2) “I could not get going.” If the participants feel tired all of the time, at least 3 or 4 days per week, they would be determined to be positive [2].

  5. (5)

    Low activity: The physical activity questions in the Health Survey for England were taken from a validated physical activity interview [43]. A question regarding the frequency of moderate activity (such as dancing, walking at a moderate pace, cleaning the car, gardening, floor, or stretching exercises) was answered by the participants. Low physical activity was defined as answering “hardly ever” or “never”. It was different from that proposed by Fried et al. [2]. In Xu’s research, low physical activity has been evaluated using similar treatment variables [44].

Body measurement

In 1835, Adolphe Quetelet, a Belgian mathematician, astronomer, and statistician, established the concept of body mass index (BMI), which is determined by dividing body weight in kilograms by the square of height in meters (kg/m2) [45]. These days, BMI is often used in part because it is easily measured and consistently recorded in patient medical records for the routine characterization of weight status in epidemiology, clinical nutrition, and research [46]. Participants are categorized as underweight (BMI < 18.5 kg/m2), normal (18.5–24 kg/m2), overweight (24–28 kg/m2), and obese (≥ 28 kg/m2) [47, 48].

Covariates

Age, sex (male and female), educational levels, marital status, current residence (rural and urban), current smoking, alcohol drinking, taking activities, chronic diseases, BMI at baseline, and entry wave (Waves 1, 2, and 3) were incorporated as covariates in the present research. (1) There were four age groups: under 45–54, 55–64, 65–74, and over 75 years old. (2) Educational levels, including illiterate (no formal education), less than elementary school (did not complete primary school but were able to write and graduate from home school, elementary school, or middle school), high school, and above vocational school (graduate from a two- or three-year college, graduate from an undergraduate college, graduate from a post-graduate). (3) There were two categories for marital status: single (not married, separated, divorced, or widowed) and married. (4) There were two categories for current residence: rural and urban. (5) There were three categories for current smoking: current smoker, former smoker, and never smoker. (6) There were three categories for alcohol drinking: never drinkers, less than once a month, and more than once a month. (7) There were two categories for taking activities (interacted with friends/helped family, friends or neighbors who don’t live with you and didn’t charge you for it/visited a club for sports, social, or another form/went to a community club, played chess, played cards, or played mahjong/participated in a community-related organization/done charity or voluntary work/looked after an ill or disabled adult who was not staying with you and didn’t pay you for your assistance/participated in a training or educational activity/stock investment /used the Internet): as ever (at least once a month) and never. (8) Chronic diseases were defined according to whether a doctor told individuals they had any of the following conditions: hypertension, diabetes or high blood sugar, cancer or malignant tumor (excluding minor skin cancers), dyslipidemia, chronic lung diseases, liver disease (except fatty liver, tumors, and cancer), kidney disease (except for tumor or cancer), heart attack, angina, coronary heart disease, congestive heart failure, or other heart problems, stomach or other digestive disease (except for tumor or cancer), stroke, memory-related disease, emotional, nervous, or psychiatric problems, arthritis or rheumatism, and asthma. Among the 14 common chronic diseases, which have a range of 0 to 14, a continuous variable is used to represent the presence of chronic health issues [49]. There were three categories for chronic disease, with the numbers of the condition being 0, 1–2, and 3–14, respectively. The categories of variables have been widely used in previous research studies [47, 48, 50,51,52,53].

Statistical analysis

The study used IBM SPSS version 25.0 (Chicago, IL, USA) for all statistical analyses. The distribution of categorical variables was expressed as frequencies and percentages and analyzed by chi-square. Binary logistic regression was used to analyze the odds ratio (OR) and 95% confidence interval (CI) for the association of exposure (depressive symptoms at baseline) with the onset of the outcome (frailty and its components) in the individuals at baseline in this study. Frailty was analyzed as a binary dependent variable (no-frail and frail), and covariates were included in the regression models in steps. Model 1 included depressive symptoms only; Model 2 additionally included social-demographic characteristics (age, sex, educational levels, marital status, and living place); Model 3 additionally included health behaviors and conditions (current smoking, alcohol drinking, activities, and chronic diseases); and Model 4 further included body measure (BMI). Cross-sectional analysis approaches were used to model covariates. P < 0.05 was considered statistically significant for all statistical analyses.

Results

Table 1 shows the baseline characteristics of participants according to the level of frailty. The mean age of participants was 61.06 ± 10.12; 62.03% were female; 84.00% were married; and 91.75% were living in rural areas. 8.99% were former smokers, and 24.60% were current smokers; 7.09% were drinking less than once a month, and 19.33% were drinking more than once a month; 49.24% were taking activities; 51.34% had 1–2 chronic diseases, and 27.16% had 3–14 chronic diseases. The frequency of frailty was 11.62%. The differences among participants with or without frailty were observed in the distribution of age, sex, educational levels, marital status, live place, current smoking, alcohol drinking, activities, chronic diseases, and BMI categories.

Table 1 Baseline characteristics of participants according to the level of frail in CHARLS Waves2011

Table 2 shows the baseline characteristics of participants according to the level of depression. A total of 2581 robust participants (42.08%) and depressive symptoms (57.92%) at baseline were included in the cross-sectional analysis. The differences in depressive symptoms were observed in the distribution of age, sex, educational levels, marital status, live place, current smoking, alcohol drinking, chronic diseases, and frailty.

Table 2 Baseline characteristics of participants according to the level of depressive symptoms in CHARLS Waves2011

Table 3 shows baseline characteristics classified according to subsequent onset of frailty. In the short-term (2 years from 2011 to 2013), participants who developed frailty were more likely to with less than elementary school education and to live in rural areas. They tend to have 1–2 chronic diseases. In the long-term (4 years from 2011 to 2015), participants who developed frailty were also more likely to with less than elementary school education and to take no part in activities. They tend to have 1–2 chronic diseases.

Table 3 Baseline characteristics classified according to subsequent onset of frail

Table 4 shows the cross-sectional relationship between depressive symptoms and frailty at baseline. Depressive symptoms (OR = 5.222, 95%CI 3.665–7.422) were significantly associated with frailty after adjusting for age, sex, educational levels, marital status, live place, current smoking, alcohol drinking, activities, chronic diseases, and BMI (adjusted model 4). In the depressive symptoms, after adjusting for the full set of covariates, depression was associated with weakness (OR = 2.037, 95%CI 1.510–2.748), slowness (OR = 1.858, 95%CI 1.528–2.259), weight loss (OR = 1.531, 95%CI 1.170–2.004), and exhaustion (OR = 12.140, 95%CI 9.903–14.882). However, depressive symptoms were not associated with low physical activity (OR = 1.207, 95%CI 0.957–1.521).

Table 4 Odds ratios (ORs) and 95% confidence interval (CIs) for frailty and components of frailty at baseline associated with depressive symptoms at baseline (N = 2581)

Table 5 shows the prospective associations between baseline depressive symptoms and frailty at 2- and 4-year follow-up survey in the participants without frailty at baseline. Firstly, in crude analysis, depressive symptoms were significantly associated with incident frailty during the short-term (OR = 2.148, 95%CI 1.323–3.488). Secondly, in crude analysis, the depressive symptoms (OR = 2.032, 95%CI 1.107–3.731) were significantly associated with incident frailty during the long-term. Thirdly, after adjusting for age, sex, educational levels, marital status, live place, current smoking, alcohol drinking, activities, chronic diseases, and BMI, the depressive symptoms (OR = 2.193, 95%CI 1.324–3.631) were significantly associated with incident frailty during the short-term. Lastly, after adjusting for the full set of covariates, the OR for depressive symptoms was 1.926 (95%CI 1.021–3.632) during the long-term.

Table 5 Association between depressive symptoms and incident frailty not frailty at baseline (2011® 2013, N = 1068; 2011® 2015, N = 607)

Table 6 shows the association between depressive symptoms and components of frailty in 2011–2013, not frailty at baseline. Firstly, in crude analysis, frailty (OR = 2.148, 95%CI 1.323–3.488) risk was increased for the depressive symptoms during the short-term. Secondly, depressive symptoms were significantly associated with incident frailty which included weakness, slowness, weight loss, exhaustion and low activity [(weakness: OR = 2.003, 95%CI 1.279–3.316), (slowness: OR = 1.375, 95%CI 1.045–1.809), (weight loss: OR = 1.517, 95%CI 1.031–2.232), (exhaustion: OR = 2.878, 95%CI 2.212–3.744), (low activity: OR = 0.648, 95%CI 0.455, 0.924)] during the short-term. Thirdly, after adjusting for age, sex, educational levels, marital status, live place, current smoking, alcohol drinking, activities, chronic diseases, and BMI, depressive symptoms were significantly associated with frailty (OR = 2.193, 95%CI 1.324–3.631), weakness (OR = 1.990, 95%CI 1.250–3.166), slowness (OR = 1.395, 95%CI 1.044–1.865), and exhaustion (OR = 2.827, 95%CI 2.150–3.719) during the short-term. However, depressive symptoms were not significantly associated with weight loss and low activity [(weight loss: OR = 1.374, 95%CI 0.923, 2.046), (low activity: OR = 0.695, 95%CI 0.481–1.004)].

Table 6 Odds ratios (ORs) and 95% confidence interval (CIs) for frailty and components of frailty at baseline associated with depressive symptoms at 2011→ 2013 (N = 1068)

Table 7 shows the association between depressive symptoms and components of frailty in 2011–2015, not frailty at baseline. Firstly, in crude analysis, frailty (OR = 2.032, 95%CI 1.107–3.731) risk was increased for the depressive symptoms during the long-term. Secondly, depressive symptoms were significantly associated with exhaustion (OR = 2.904, 95%CI 2.052–4.111) during the long-term. However, depressive symptoms were not significantly associated with weakness, slowness, weight loss, or low activity [(weakness: OR = 1.107, 95%CI 0.727–1.685), (slowness: OR = 0.916 95%CI 0.637–1.316), (weight loss: OR = 1.620, 95%CI 0.866–3.029), (low activity: OR = 0.823, 95%CI 0.519–1.306)]. Thirdly, after adjusting for age, sex, educational levels, marital status, live place, current smoking, alcohol drinking, activities, chronic diseases, and BMI, depressive symptoms was significantly associated with frailty (OR = 1.926, 95%CI 1.021–3.632) and exhaustion (OR = 2.869, 95%CI 2.004–4.109) during the long-term. However, depressive symptoms were not significantly associated with weakness, slowness, weight loss, or low activity [(weakness: OR = 0.983, 95%CI 0.630–1.534), (slowness: OR = 0.845, 95%CI 0.576–1.239), weight loss: OR = 1.503, 95%CI 0.666–3.393), (low activity: OR = 0.839, 95%CI 0.520–1.353)].

Table 7 Odds ratios (ORs)) and 95% confidence interval (CIs) for frailty and components of frailty at baseline associated with depressive symptoms at 2011→ 2015 (N = 607)

Discussion

The cross-sectional and longitudinal associations between depressive symptoms and frailty and its components were described in this research. First, it has been found that depressive symptoms at baseline were related to frailty and its components (weakness, slowness, weight loss, and exhaustion). Secondly, depressive symptoms at baseline were significantly associated with the onset of frailty after two years of follow-up. Among specific criteria, weakness, slowness, and exhaustion were significant independent predictors of future frailty. Lastly, depressive symptoms at baseline were significantly associated with the onset of frailty after four years of follow-up. Among specific criteria, exhaustion was a significant independent predictor of future frailty. Depression symptoms should be evaluated for prevention, as they may be a potential future risk factor for future frailty.

To date, a limited amount of research has explored the influence of depression on frailty and its components over a period of years. At the same time, in the meta-analysis, most participants were Western. This research aimed to investigate the association between depressive symptoms and the incidence of frailty and its components in Asian participants, who are middle-aged and older. Previous studies have shown that depressive symptoms have been related to an increased risk of frailty and its similar components, such as cognitive decline, reduced social and physical activity (e.g., as a result of muscular atrophy), memory consolidation, mental flexibility and somatic health decline [54,55,56,57]. Soysal’s research also found that depressive symptoms often lead to weight loss, slow gait speed, poor social relationships, and malnutrition [22]. In addition, Veronese et al. deemed that depressive symptoms can lead to fatigue, weakness, and mobility impairments [58]. These factors may raise the risk of frailty and increased mortality during a five-year period. The above studies are partly in accordance with this research. Results from the present longitudinal data in this research indicate that depressive symptoms are associated with an increased risk of incident frailty after 2 and 4 years of follow-up in the middle-aged and older adults aged 45–96 years. The differences between our research and the previously referenced studies in the literature could be explained by some hypotheses. First, differences in evaluation tools for frailty and depressive symptoms, covariates, and length of follow-up could play an important role. There are 10-item, 15-item, and 20-item Epidemiologic Studies-Depression Scales. This research used a 10-item Epidemiologic Studies-Depression Scale to evaluate depressive symptoms. Second, the transcultural differences, the population, and the data collection may contribute to these differences in the results. Finally, we used the revised Fried’s criteria, which may influence the results [2].

The mechanisms that underline the association between depressive symptoms and the incidence of frailty and its components are still unknown. Some hypotheses could explain the significant association between depressive symptoms and the onset of weakness, slowness, and exhaustion. First, due to the decline in social ties, gait speed, and reduced physical activity, as well as the rise in sedentary lifestyles, weight loss, fall risk, and malnourishment, depression may be predictive of frailty [17, 59]. Persons with depressive symptoms are on average unhealthier; compared to their peers who are not depressed, those who are depressed tend to be less physically active, drink excessive amounts of alcohol, and eat unhealthy diets [60]. The use of antidepressant has been connected to some same outcomes as frailty, such as fracture, osteoporosis, and falls [61,62,63]. Depressive symptoms could also lead to cognitive impairment, sleep disturbance, poor nutritional status, and emotional disorders, which may seriously affect frailty and physical health [64,65,66,67,68]. Furthermore, there may be an association between the development of depressive symptoms and somatic diseases because depressed individuals have been found to have lower levels of self-care and general health regimen compliance [69]. These factors may also prolong the depressive symptoms, such as sadness, hopelessness, and anhedonia. Second, common risk factors and pathophysiologic pathways may exist. Overlapping mechanisms can partly explain these, such as chronic inflammation, cerebrovascular disease, oxidative stress, hypothalamic-pituitary-adrenal dysfunction, mitochondrial, and axis dysregulation [22, 70,71,72]. At the same time, subclinical vascular diseases, which result in pre-frontal white-matter hyperintensities in individuals with late-life depressive symptoms, have long been recognized as a critical factor in prefrailty [73]. Third, the level of the inflammatory cytokines, for example, interleukin 6 (IL 6), will be raised in individuals with late-life depressive symptoms [20]. In addition to having a negative impact on central dopaminergic function, inflammatory cytokines are linked to decreased muscular mass and strength; these effects may also cause fatigue and motor slowing [71]. Finally, mitochondrial dysfunction may be a key factor. Patients with depression found reduced ATP (adenosine triphosphate) generation in their muscle biopsies [71]. Peripheral blood mononuclear cells from people with depression showed decreased mitochondrial respiration, which was most closely correlated with the fatigue symptom [71].

For older people with frailty, physical activity is a beneficial intervention. Through possible neurobiological changes, as well as a result of physical and social engagement, it may prevent and manage depression symptoms among older people [71, 74, 75]. Among middle-aged and older adults, interventions aimed at preventing depressive symptoms may be beneficial in reducing frailty and its components [76,77,78].

Strengthes and limitations of the study

The research has several strengths. First, the research was based on a nationwide population-based longitudinal study, which included 17,104 adults aged 45 and above. It ensures the accuracy of this study and therefore can be considered nationally representative. It means the results may be used for “cause inference”. Second, the measures of depressive symptoms and frailty were widely applied and validated instruments to thoroughly understand the research questions. Finally, it investigated how depression symptoms affected frailty and its components at two distinct intervals. The connection between depressive symptoms and frailty was identified in previous research only at a single interval. It improves our understanding of the short- and long-term effects of depressive symptoms on the incidence of frailty.

Several limitations of this research should be noted. First, this study only considered the effect of depressive symptom, and did not consider the impact of occurrence of new diseases or geriatric syndromes on incident frailty during 2-year or 4-year follow-up. Second, this research applied a complete case analysis strategy by excluding those with missing exposure, outcome, and cofounders’ data. These factors may lead to biased results. Third, in this study, the depressive symptom was evaluated subjectively by was self-reported, and there was an attrition rate, which could potentially affect the results. Finally, it was a longitudinal study and excluded those already frailty at baseline, but the possibility that the frailty components presented years later occurred at or even before the baseline examination could not be excluded. This may have an impact on the results of the study. So future studies need to enhance these aspects.

Conclusions

Among middle-aged and older adults, depressive symptoms could predict frailty during 2 years of follow-up and 4 years of follow-up. When considering potential confounding factors, depressive symptoms were considered a predictor of weakness, slowness, and exhaustion. Interventions aimed at preventing depressive symptoms may be beneficial in reducing frailty and its components. This research provides new evidence between depressive symptoms and frailty for a causal relation and helps promote healthy aging for middle-aged and older adults.

Data availability

The data that support the findings of this research are available from the public, open-access website (https://charls.pku.edu.cn/).

Abbreviations

CHARLS:

China Health and Retirement Longitudinal Study

CAPI:

Computer-aided personal interview

HRs:

Hazard ratios

OR:

Odds ratio

BMI:

Body mass index

kg/m2 :

Kilogram/meter2

M:

Mean

SD:

Standard deviation

Cis:

Confidence intervals

CESD:

Chinese version of the Center for Epidemiologic Studies-Depression Scale

IL-6:

Interleukin-6

ATP:

Adenosine triphosphate

NSFC:

The National Natural Science Foundation of China

NIA:

National Institute on Aging

WB:

World Bank

References

  1. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet (London England). 2013;381(9868):752–62.

    Article  PubMed  Google Scholar 

  2. Fried LPTC, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA. Frailty in older adults: evidence for a phenotype. Journals Gerontol Ser A-biological Sci Med Sci. 2001;56(3):146–56.

    Google Scholar 

  3. Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394(10206):1365–75.

    Article  PubMed  Google Scholar 

  4. Cui R. Editorial: a systematic review of Depression. Curr Neuropharmacol. 2015;13(4):480.

    Article  CAS  PubMed  Google Scholar 

  5. Fried EI. Moving forward: how depression heterogeneity hinders progress in treatment and research. Expert Rev Neurother. 2017;17(5):423–5.

    Article  CAS  PubMed  Google Scholar 

  6. Fiske A, Wetherell JL, Gatz M. Depression in older adults. Ann Rev Clin Psychol. 2009;5(1):363–89.

    Article  Google Scholar 

  7. Beekman ATPB, Deeg DJ, de Beurs E, Geerling SW, van Tilburg W. The impact of depression on the well-being, disability and use of services in older adults: a longitudinal perspective. Acta Psychiatr Scand. 2002;105(1):20–7.

    Article  PubMed  Google Scholar 

  8. Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34(1):119–38.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Rodda J, Walker Z, Carter J. Depression in older adults. BMJ. 2011;343:d5219.

    Article  PubMed  Google Scholar 

  10. Levinson D, Lakoma MD, Petukhova M, Schoenbaum M, Zaslavsky AM, Angermeyer M, Borges G, Bruffaerts R, de Girolamo G, de Graaf R, et al. Associations of serious mental illness with earnings: results from the WHO World Mental Health surveys. Br J Psychiatry. 2018;197(2):114–21.

    Article  Google Scholar 

  11. Lee S, Tsang A, Breslau J, Aguilar-Gaxiola S, Angermeyer M, Borges G, Bromet E, Bruffaerts R, de Girolamo G, Fayyad J, et al. Mental disorders and termination of education in high-income and low- and middle-income countries: epidemiological study. Br J Psychiatry. 2018;194(5):411–7.

    Article  Google Scholar 

  12. Luppa M, Sikorski C, Luck T, Ehreke L, Konnopka A, Wiese B, Weyerer S, König HH, Riedel-Heller SG. Age- and gender-specific prevalence of depression in latest-life – systematic review and meta-analysis. J Affect Disord. 2012;136(3):212–21.

    Article  CAS  PubMed  Google Scholar 

  13. Vanoh D, Shahar S, Yahya HM, Hamid TA. Prevalence and determinants of Depressive disorders among Community-dwelling older adults: findings from the towards useful aging study. Int J Gerontol. 2016;10(2):81–5.

    Article  Google Scholar 

  14. Wu CSYS, Lee CY, Tseng HY, Chiu YF, Hsiung CA. Prevalence of and risk factors for minor and major depression among community-dwelling older adults in Taiwan. Int Psychogeriatr. 2017;29(7):1113–21.

    Article  PubMed  Google Scholar 

  15. Jung HWJI, Lee YS, Lee CK, Cho EI, Kang WY, Chae JH, Lee EJ, Kim DH. Prevalence of Frailty and Aging-Related Health conditions in older koreans in Rural communities: a cross-sectional analysis of the Aging Study of Pyeongchang Rural Area. J Korean Med Sci. 2016;31(3):345–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Collard RM, Comijs HC, Naarding P, Oude Voshaar RC. Physical frailty: vulnerability of patients suffering from late-life depression. Aging Ment Health. 2013;18(5):570–8.

    Article  PubMed  Google Scholar 

  17. Hajek ABC, Posselt T, Lange C, Mamone S, Wiese B, Weyerer S, Werle J, Fuchs A, Pentzek M, Stein J, Luck T, Bickel H, Mösch E, Heser K, Jessen F, Maier W, Riedel-Heller SM, König SG. Predictors of frailty in old age - results of a longitudinal study. J Nutr Health Aging. 2016;20(9):952–7.

    Article  CAS  PubMed  Google Scholar 

  18. Chu W, Chang SF, Ho HY, Lin HC. The relationship between Depression and Frailty in Community-Dwelling Older people: a systematic review and Meta‐analysis of 84,351 older adults. J Nurs Scholarsh. 2019;51(5):547–59.

    Article  PubMed  Google Scholar 

  19. Maștaleru AAI, Ștefăniu R, Lefter N, Sandu IA, Pîslaru AI, Leon-Constantin MM, Alexa ID, Ilie AC. Relationship between Frailty and Depression in a Population from North-Eastern Romania. Int J Environ Res Public Health. 2022;19(9):5731.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Vaughan L, Goveas J, Corbin A. Depression and frailty in later life: a systematic review. Clin Interv Aging. 2015;10:1947–58.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chen Z, Jiang X, Shi G, Wang Y, Chu X, Wang Z, Guo J, Zhu Y, Chen J, Wang X, et al. Social Frailty and longitudinal risk of depressive symptoms in a Chinese population: the Rugao Longevity and Aging Study. Psychogeriatrics. 2021;21(4):483–90.

    Article  PubMed  Google Scholar 

  22. Soysal P, Veronese N, Thompson T, Kahl KG, Fernandes BS, Prina AM, Solmi M, Schofield P, Koyanagi A, Tseng P-T, et al. Relationship between depression and frailty in older adults: a systematic review and meta-analysis. Ageing Res Rev. 2017;36:78–87.

    Article  PubMed  Google Scholar 

  23. Fugate Woods N, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, Masaki K, Murray A, Newman AB. Frailty: emergence and consequences in women aged 65 and older in the women’s Health Initiative Observational Study. J Am Geriatr Soc. 2005;53(8):1321–30.

    Article  Google Scholar 

  24. Mezuk B, Lohman M, Dumenci L, Lapane KL. Are Depression and Frailty overlapping syndromes in Mid- and Late-life? A latent variable analysis. Am J Geriatric Psychiatry. 2013;21(6):560–9.

    Article  Google Scholar 

  25. Ma L, SF, Tang Z. Social Frailty is Associated with Physical Functioning, Cognition, and Depression, and predicts mortality. J Nutr Health Aging. 2018;22(8):989–95.

    Article  CAS  PubMed  Google Scholar 

  26. Makizako HSH, Doi T, Yoshida D, Anan Y, Tsutsumimoto K, Uemura K, Liu-Ambrose T, Park H, Lee S, Suzuki T. Physical Frailty Predicts Incident depressive symptoms in Elderly people: prospective findings from the Obu Study of Health Promotion for the Elderly. J Am Med Dir Assoc. 2015;16(3):194–9.

    Article  PubMed  Google Scholar 

  27. Feng LNM, Feng L, Yap KB, Ng TP. Frailty Predicts New and Persistent Depressive Symptoms Among Community-Dwelling Older Adults: Findings From Singapore Longitudinal Aging Study. Journal of the American Medical Directors Association 2014, 15(1):76.e77-76.e12.

  28. Zhao YHY, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2012;43(1):61–8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Li CLT, Sun W, Wu L, Zou ZY. Prevalence and risk factors of arthritis in a middle-aged and older Chinese population: the China Health and Retirement Longitudinal Study. Rheumatology (Oxford). 2015;54(4):697–706.

    Article  PubMed  Google Scholar 

  30. Grzywacz JGHJ, Seligman LD, Arcury TA, Quandt SA. Evaluating short-form versions of the CES-D for measuring depressive symptoms among immigrants from Mexico. Hispanic J Behav Sci. 2006;28(3):404–24.

    Article  Google Scholar 

  31. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for Depression in well older adults: evaluation of a short form of the CES-D. Am J Prev Med. 1994;10(2):77–84.

    Article  CAS  PubMed  Google Scholar 

  32. KW B. Cross-validation of a short form of the CES-D in Chinese elderly. Int J Geriatr Psychiatry. 1999;14(8):608–17.

    Article  Google Scholar 

  33. Xu YYJ, Gao J, Zhou Z, Zhang T, Ren J, Li Y, Qian Y, Lai S, Chen G. Decomposing socioeconomic inequalities in depressive symptoms among the elderly in China. BMC Public Health. 2016;16(1):1214.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Cheng HGCS, McBride O, Phillips MR. Prospective relationship of depressive symptoms, drinking, and tobacco smoking among middle-aged and elderly community-dwelling adults: results from the China Health and Retirement Longitudinal Study (CHARLS). J Affect Disord. 2016;195:136–43.

    Article  PubMed  Google Scholar 

  35. Lei XSX, Strauss J, Zhang P, Zhao Y. Depressive symptoms and SES among the mid-aged and elderly in China: evidence from the China Health and Retirement Longitudinal Study national baseline. Soc Sci Med. 2014;120:224–32.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Chen HMA. Factorial validity of the Center for Epidemiologic Studies Depression Scale short form in older population in China. Int Psychogeriatr. 2013;26(1):49–57.

    Article  PubMed  Google Scholar 

  37. Nordin E, Lindelöf N, Rosendahl E, Jensen J, Lundin-olsson L. Prognostic validity of the timed Up-and-Go test, a modified Get-Up-and-Go test, staff’s global judgement and fall history in evaluating fall risk in residential care facilities. Age Ageing. 2008;37(4):442–8.

    Article  PubMed  Google Scholar 

  38. Sletvold OTR, Jonsson A, Schroll M, Snaedal J, Engedal K, Schultz-Larsen K, Gustafson Y. The nordic approach to comprehensive geriatric assessment. Dan Med Bull. 1996;43(4):350–9.

    CAS  PubMed  Google Scholar 

  39. ME M. Guideline for the prevention of falls in older persons’: essential reading. Age Ageing. 2002;31(1):13–4.

    Article  Google Scholar 

  40. Podsiadlo DRS. The timed up & go: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8.

    Article  CAS  PubMed  Google Scholar 

  41. Veronese NSM, Maggi S, Noale M, Sergi G, Manzato E, Prina AM, Fornaro M, Carvalho AF, Stubbs B. Frailty and incident depression in community-dwelling older people: results from the ELSA study. Int J Geriatr Psychiatry. 2017;32(12):e141–9.

    Article  PubMed  Google Scholar 

  42. Theou OCL, Blodgett J, Wallace LM, Brothers TD, Rockwood K. Modifications to the frailty phenotype criteria: systematic review of the current literature and investigation of 262 frailty phenotypes in the Survey of Health, Ageing, and Retirement in Europe. Ageing Res Rev. 2015;21:78–94.

    Article  PubMed  Google Scholar 

  43. Gale CR, Cooper C, Deary IJ, Aihie Sayer A. Psychological well-being and incident frailty in men and women: the English Longitudinal Study of Ageing. Psychol Med. 2013;44(4):697–706.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Xu WLY, Wu C. Incidence of frailty among community-dwelling older adults: a nationally representative profile in China. BMC Geriatr. 2019;19(1):378.

    Article  PubMed  PubMed Central  Google Scholar 

  45. LA. A treatise on man and the development of his faculties.1842. Obes Res. 1994;2(1):72–85.

    Article  Google Scholar 

  46. Müller MJ, Braun W, Enderle J, Bosy-Westphal A. Beyond BMI: conceptual issues related to overweight and obese patients. Obes Facts. 2016;9(3):193–205.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Zhang LLK, Li H, Li D, Chen Z, Zhang LL, Guo LL. Body mass index and serum uric acid level. Medicine. 2020;99(9):e19418.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Zhang LLJ, Zhang LL, Guo LL, Li H, Li D. Association and Interaction Analysis of Body Mass Index and Triglycerides Level with Blood Pressure in Elderly Individuals in China. BioMed Research International 2018, 2018:8934534.

  49. Chang H-H, Yen ST. Association between obesity and depression: evidence from a longitudinal sample of the elderly in Taiwan. Aging Ment Health. 2012;16(2):173–80.

    Article  PubMed  Google Scholar 

  50. Zhang LLJ, Guo LL, Li H, Li D, Xu G. The interaction between serum uric acid and triglycerides level on blood pressure in middle-aged and elderly individuals in China: result from a large national cohort study. BMC Cardiovasc Disord. 2020;20(1):174.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Zhang LLK, Li H, Li D, Chen Z, Zhang LL, Guo LL. Relationship between adiposity parameters and cognition: the fat and jolly hypothesis in middle-aged and elderly people in China. Medicine 2019, 98(10).

  52. Zhang LLJ, Zhang LL, Guo LL, Li H, Li D. No association between C-reactive protein and depressive symptoms among the middle-aged and elderly in China: evidence from the China Health and Retirement Longitudinal Study. Medicine. 2018;97(38):e12352.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Zhang LLK, Li H, Li D, Chen Z, Zhang LL, Guo LL. Relationship between body mass index and depressive symptoms: the fat and jolly hypothesis for the middle-aged and elderly in China. BMC Public Health. 2016;16(1):1201.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Mehta KTS, Mohebbi M, Pasco JA, Williams LJ, Walder K, Ng BL, Gupta VB. Depression and bone loss as risk factors for cognitive decline: a systematic review and meta-analysis. Ageing Res Rev. 2022;76:101575.

    Article  CAS  PubMed  Google Scholar 

  55. Yatawara C, Lim L, Chander R, Zhou J, Kandiah N. Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment. J Neurol Neurosurg Psychiatry. 2016;87(12):1375–83.

    Article  PubMed  Google Scholar 

  56. Penninx BWMY, Lamers F, Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013;11:129.

    Article  PubMed  PubMed Central  Google Scholar 

  57. TB V. Frailty in the elderly: contributions of Sarcopenia and visceral protein depletion. Metabolism-clinical Experimental. 2003;52:22–6.

    Article  Google Scholar 

  58. Veronese NSB, Fontana L, Trevisan C, Bolzetta F, Rui M, Sartori L, Musacchio E, Zambon S, Maggi S, Perissinotto E, Corti MC, Crepaldi G, Manzato E, Sergi G. A comparison of Objective Physical Performance tests and future mortality in the Elderly people. Journals Gerontol Ser A-biological Sci Med Sci. 2016;72(3):362–8.

    Google Scholar 

  59. Paulson D, Lichtenberg PA. Vascular depression: an early warning sign of frailty. Aging Ment Health. 2013;17(1):85–93.

    Article  PubMed  Google Scholar 

  60. van Gool CHKG, Bosma H, van Boxtel MP, Jolles J, van Eijk JT. Associations between Lifestyle and Depressed Mood: longitudinal results from the Maastricht Aging Study. Am J Public Health. 2007;97(5):887–94.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Ensrud KEBT, Mangione CM, Bowman PJ, Whooley MA, Bauer DC, Schwartz AV, Hanlon JT, Nevitt MC, Study of Osteoporotic Fractures Research Group. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc. 2002;50(10):1629–37.

    Article  PubMed  Google Scholar 

  62. Takkouche BM-MA, Gill SS, Etminan M. Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf. 2007;30(2):171–84.

    Article  PubMed  Google Scholar 

  63. Mezuk BEW, Golden SH, Wand G, Lee HB. Depression, antidepressants, and bone mineral density in a population-based cohort. J Gerontol Biol Sci Med Sci. 2008;63(12):1410–5.

    Article  Google Scholar 

  64. Rock PLRJ, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44(10):2029–40.

    Article  CAS  PubMed  Google Scholar 

  65. Searle SDRK. Frailty and the risk of cognitive impairment. Alzheimers Res Ther. 2015;7(1):54.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Wei KNM, Gao Q, Wee SL, Ng TP. Frailty and Malnutrition: related and distinct Syndrome Prevalence and Association among Community-Dwelling older adults: Singapore Longitudinal Ageing studies. J Am Med Dir Assoc. 2017;18(12):1019–28.

    Article  PubMed  Google Scholar 

  67. Li SMH, Yuan X, Zhou X, Wan Y, Chen S. MicroRNA-382-5p targets nuclear receptor subfamily 3 Group C Member 1 to regulate Depressive-Like behaviors Induced by Chronic unpredictable mild stress in rats. Neuropsychiatr Dis Treat. 2020;16:2053–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Park SKOC, Ryoo JH, Jung JY. The protective effect of mushroom consumption on depressive symptoms in Korean population. Sci Rep. 2022;12(1):21914.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. DiMatteo MRLH, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–7.

    Article  CAS  PubMed  Google Scholar 

  70. Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R, Sergi G, Isik AT, Manzato E, Maggi S, et al. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev. 2016;31:1–8.

    Article  CAS  PubMed  Google Scholar 

  71. Brown PJ, Roose SP, Fieo R, Liu X, Rantanen T, Sneed JR, Rutherford BR, Devanand DP, Avlund K. Frailty and Depression in older adults: A High-Risk Clinical Population. Am J Geriatric Psychiatry. 2014;22(11):1083–95.

    Article  Google Scholar 

  72. Katz IR. Depression and Frailty: the need for Multidisciplinary Research. Am J Geriatric Psychiatry. 2004;12(1):1–5.

    Article  Google Scholar 

  73. Newberg AR, Davydow DS, Lee HB. Cerebrovascular disease basis of depression: post-stroke depression and vascular depression. Int Rev Psychiatry. 2009;18(5):433–41.

    Article  Google Scholar 

  74. Schuch FB, Vancampfort D, Rosenbaum S, Richards J, Ward PB, Veronese N, Solmi M, Cadore EL, Stubbs B. Exercise for depression in older adults: a meta-analysis of randomized controlled trials adjusting for publication bias. Revista Brasileira De Psiquiatria. 2016;38(3):247–54.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Schuch FB, Deslandes AC, Stubbs B, Gosmann NP, Silva CTBd. Fleck MPdA: neurobiological effects of exercise on major depressive disorder: a systematic review. Neurosci Biobehavioral Reviews. 2016;61:1–11.

    Article  Google Scholar 

  76. Zhu JZD, Nie Y, Wang J, Yang Y, Chen D, Yu M, Li Y. Assessment of the bidirectional causal association between frailty and depression: a mendelian randomization study. J Cachexia Sarcopenia Muscle. 2023;14(5):2327–34.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Deng MGLF, Liang Y, Wang K, Nie JQ, Liu J. Association between frailty and depression: a bidirectional mendelian randomization study. Sci Adv. 2023;9(38):eadi3902.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Chu XFZN, Shi GP, Wang Y, Wang ZD, Guo JH, Jiang XY, Jin L, Wang XF, Zhu YS. Frailty and incident depressive symptoms in a Chinese sample: the Rugao Longevity and Ageing Study. Psychogeriatrics. 2020;20(5):691–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We appreciate all participants, as well as the members of the research team for their time and contribution.

Funding

This work was supported by the NSFC (70910107022, 71130002) and National Institute on Aging (R03-TW008358-01; R01-AG037031-03S1), World Bank (7159234), and the publication fee was supported by the Scientific Research Projects of universities in Anhui Province (2023AH051730).

Author information

Authors and Affiliations

Authors

Contributions

Conceived and designed the research: TY, LZ. Wrote the paper: YHS. Analyzed the data: YHS, TY, and LZ. Revised the paper: YHS, TY, LZ, XDL, HYL, YQL, JFG, XYZ, XPL, LS, CZW, LY, JL, MML, DMZ, YH, and YXL. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Ting Yuan.

Ethics declarations

Ethics approval and consent to participate

Approval for this study was given by the Medical Ethics Committee of Wannan Medical College (Approval Number2021-3). The patients/participants provided their written informed consent to participate in this study.

Consent to publish

The completion of the all-author declaration and consent to publish form is required.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, Y., Li, X., Liu, H. et al. Predictive role of depressive symptoms on frailty and its components in Chinese middle-aged and older adults: a longitudinal analysis. BMC Public Health 24, 2201 (2024). https://doi.org/10.1186/s12889-024-19627-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-024-19627-y

Keywords